Clinical Trial Update: A Clinical Study to Observe the Safety and Efficacy of ScTIL210 in the Treatment of Malignant Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update for ScTIL210 assessing safety and efficacy in malignant solid tumors (Phase 1/Phase 2).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Solid Tumor

Drugs mentioned

• ScTIL210

Snippet

Sponsor: Shanghai East Hospital | Conditions: Malignant Solid Tumor | Phase 1, Phase 2 | Status: UNKNOWN